Barbara Hasse

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
    Clin Infect Dis 51:1314-22. 2010
  2. doi request reprint Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    Clin Infect Dis 53:1130-9. 2011
  3. doi request reprint Vascular graft infections
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Switzerland
    Swiss Med Wkly 143:w13754. 2013
  4. ncbi request reprint Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    AIDS Res Hum Retroviruses 20:909-15. 2004
  5. pmc Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Zurich, Switzerland
    Antimicrob Agents Chemother 58:2363-8. 2014
  6. ncbi request reprint Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1
    Christine Schraner
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
    Clin Infect Dis 40:e120-4. 2005
  7. ncbi request reprint Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy
    Jean Philippe Zuber
    University and Cantonal Hospitals of Zurich, Zurich, Switzerland
    Clin Infect Dis 38:1178-85. 2004

Collaborators

Detail Information

Publications7

  1. doi request reprint Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
    Clin Infect Dis 51:1314-22. 2010
    ..We studied the frequency, changes over time, and determinants of unprotected sex among HIV-positive persons...
  2. doi request reprint Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    Clin Infect Dis 53:1130-9. 2011
    ..We studied the influence of aging on the epidemiology of non-AIDS diseases in the Swiss HIV Cohort Study...
  3. doi request reprint Vascular graft infections
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Switzerland
    Swiss Med Wkly 143:w13754. 2013
    ..Additionally, empirical treatment might include rifampicin since it penetrates well into biofilms...
  4. ncbi request reprint Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    AIDS Res Hum Retroviruses 20:909-15. 2004
    ..92 versus 2.17 years, p = 0.30). In conclusion, AVN could not be attributed to time on antiretroviral treatment, but patients with AVN had histories of more severe immunosuppression and a higher body mass index than controls...
  5. pmc Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Zurich, Switzerland
    Antimicrob Agents Chemother 58:2363-8. 2014
    ..70 (95% confidence interval [CI], 0.55 to 0.89) and 0.87 (95% CI, 0.74 to 1.0), respectively. Co-trimoxazole may prevent the development of TB among HIV-positive persons, especially among those with no previous ART. ..
  6. ncbi request reprint Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1
    Christine Schraner
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
    Clin Infect Dis 40:e120-4. 2005
    ..The skin lesions failed to respond to full treatment courses of amphotericin B, sodium stibogluconate, and liposomal amphotericin B but were successfully treated with miltefosine, an alkylphosphocholine analogue...
  7. ncbi request reprint Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy
    Jean Philippe Zuber
    University and Cantonal Hospitals of Zurich, Zurich, Switzerland
    Clin Infect Dis 38:1178-85. 2004
    ..7 years. HAART significantly decreased mortality due to PAHRH as well as other causes. This study suggests a beneficial effect of combination ART in patients with PAHRH...